Literature DB >> 16630759

Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease.

Patrick Chamouard1, Zoe Richert, Nicolas Meyer, Gabriel Rahmi, René Baumann.   

Abstract

BACKGROUND AND AIMS: Measuring Crohn's disease (CD) activity is useful in clinical trials as well as in clinical practice, but each available instrument to measure such activity has some limitations. C-reactive protein (CRP) is a sensitive marker for inflammation and tissue injury. The aims of the study were: to assess the diagnostic value of low level of CRP for predicting a low CD activity, and to calculate optimal CRP cutoff value for selecting patients with moderate or high CD activity.
METHODS: One hundred fifty consecutive patients with active or nonactive CD were included in the study without any pre-selection criteria. CRP was measured, and CD activity was calculated by means of the van Hees index (VHI).
RESULTS: The median VHI score was 154.4 (interquartile range, 126.0-193.4), and the median CRP was 19.1 mg/L (interquartile range, 6.1-50.1 mg/L; upper limit of normal [N], 4 mg/L). Forty-nine percent of our patients had CRP >20 mg/L. CRP was significantly correlated to VHI (P = .0001). The probability that VHI was <150 if CRP was below upper limit of normal was equal to 1 (confidence interval, 0.891-1.000). The diagnostic value for CRP predicting a VHI > or =150 was high; the area under the receiver operating characteristic curve was equal to 0.844 (confidence interval, 0.783-0.906; P = .0001) with an optimal cutoff value of 21.6 mg/L, about 5 x N.
CONCLUSIONS: CRP appears useful to evaluate CD activity, especially to predict inactive or low activity CD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630759     DOI: 10.1016/j.cgh.2006.02.003

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  18 in total

Review 1.  Current best practice for disease activity assessment in IBD.

Authors:  Alissa J Walsh; Robert V Bryant; Simon P L Travis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-01       Impact factor: 46.802

Review 2.  C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.

Authors:  Mahmoud H Mosli; Guangyong Zou; Sushil K Garg; Sean G Feagan; John K MacDonald; Nilesh Chande; William J Sandborn; Brian G Feagan
Journal:  Am J Gastroenterol       Date:  2015-05-12       Impact factor: 10.864

3.  Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.

Authors:  Hiroshi Takeyama; Tsunekazu Mizushima; Hideki Iijima; Shinzaki Shinichiro; Mamoru Uemura; Junichi Nishimura; Taishi Hata; Ichiro Takemasa; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
Journal:  Dig Dis Sci       Date:  2015-06-16       Impact factor: 3.199

4.  CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease.

Authors:  Alexander D Rodgers; Adrian G Cummins
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.199

5.  Crohn's disease: the first visit.

Authors:  Jack A Di Palma; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-03

6.  C-reactive protein and disease activity in children with Crohn's disease.

Authors:  Samantha Tilakaratne; Daniel A Lemberg; Steven T Leach; Andrew S Day
Journal:  Dig Dis Sci       Date:  2010-01       Impact factor: 3.199

7.  C-reactive protein levels during a relapse of Crohn's disease are associated with the clinical course of the disease.

Authors:  Chantal L Koelewijn; Matthijs P Schwartz; Melvin Samsom; Bas Oldenburg
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

8.  Increased folate intake with no changes in serum homocysteine and decreased levels of C-reactive protein in patients with inflammatory bowel diseases.

Authors:  P G Chiarello; F R O Penaforte; C C Japur; C D A S Souza; H Vannucchi; L E A Troncon
Journal:  Dig Dis Sci       Date:  2008-07-17       Impact factor: 3.199

9.  Do cytokines really sing the blues?

Authors:  Charles L Raison; Andrew H Miller
Journal:  Cerebrum       Date:  2013-08-01

10.  Oral Manifestations of Crohn's Disease: A Case Report and Review of the Literature.

Authors:  Victoria L Woo
Journal:  Case Rep Dent       Date:  2015-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.